EDITAS MEDICINE INC (EDIT:NASDAQ)
$2.95 0.06 (2.0761%)
Analysed EDITAS MEDICINE INC (EDIT:NASDAQ) News Sources
Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?
08-04-2026
yahoo.com
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
07-04-2026
yahoo.com
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
27-03-2026
yahoo.com
Is Editas Medicine Going to $0?
17-03-2026
fool.com
Editas Medicine Details In Vivo CRISPR Plan, Targets Year-End Human Proof-of-Concept for EDIT-401
15-03-2026
marketbeat.com
EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y
10-03-2026
yahoo.com
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
10-03-2026
yahoo.com
Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates
09-03-2026
yahoo.com
Editas: Q4 Earnings Snapshot
09-03-2026
yahoo.com
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
09-03-2026
yahoo.com
What is the current price of EDITAS MEDICINE INC (EDIT:NASDAQ)?
The current price of EDITAS MEDICINE INC (EDIT:NASDAQ) is $2.95.
EDITAS MEDICINE INC (EDIT:NASDAQ) absolute price change since previous trading day?
The absolute price change of EDITAS MEDICINE INC (EDIT:NASDAQ) since the previous trading day is $0.06.
EDITAS MEDICINE INC (EDIT:NASDAQ) percentage price change since previous trading day?
The percentage price change of EDITAS MEDICINE INC (EDIT:NASDAQ) since the previous trading day is 2.0761%.
What is the most recent average sentiment score for EDITAS MEDICINE INC (EDIT:NASDAQ)?
The most recent average sentiment score for EDITAS MEDICINE INC (EDIT:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for EDITAS MEDICINE INC (EDIT:NASDAQ)?
The most recent sentiment for EDITAS MEDICINE INC (EDIT:NASDAQ) is .
SEC-8K** Filing Available For EDITAS MEDICINE INC (EDIT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.